The role of α-synuclein gene multiplications in early-onset Parkinson’s disease and dementia with Lewy bodies

被引:0
|
作者
A. Hofer
D. Berg
F. Asmus
M. Niwar
G. Ransmayr
M. Riemenschneider
S.-B. Bonelli
M. Steffelbauer
A. Ceballos-Baumann
P. Haussermann
S. Behnke
R. Krüger
J. Prestel
M. Sharma
A. Zimprich
O. Riess
T. Gasser
机构
[1] Hertie-Institute for Clinical Brain Research,Department of Neurodegenerative Diseases
[2] Institute for Human Genetics,Department of Medical Genetics
[3] University of Tübingen,Department of Neurology and Psychiatry
[4] General Hospital Linz,Department of Psychiatry and Psychotherapy
[5] Technical University,Department of Neurology
[6] University of Homburg/Saar,Department of Neurology
[7] Technical University,Department of General Neurology
[8] Hertie-Institute for Clinical Brain Research,undefined
[9] University of Tübingen,undefined
来源
关键词
Keywords: Alpha-synuclein, Parkinson’s disease, Lewy-body.;
D O I
暂无
中图分类号
学科分类号
摘要
Background: A triplication of the α-synuclein gene was found to cause autosomal dominant Lewy body disease in two distinct families. Method: We searched for alterations of α-synuclein gene dosage and analysed the entire coding region for point mutations in 54 dementia with Lewy body disease (DLB) and in 103 young onset Parkinson’s disease (PD) patients from Central Europe. Results: We could not detect any quantitative alterations in the gene dosage of α-synuclein. Mutational screening of the entire coding region of α-synuclein revealed only one silent mutation V3V (adenine9guanine) in one case. Conclusions: Thus, this phenomenon appears not to be a major cause in the pathogenesis of sporadic DLB and young onset PD in this European population.
引用
收藏
页码:1249 / 1254
页数:5
相关论文
共 50 条
  • [21] Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies
    Aarsland, D
    Mosimann, UP
    McKeith, IG
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2004, 17 (03) : 164 - 171
  • [22] α-synuclein immunoreactivity in Lewy bodies and abnormal neurites in Parkinson's disease and dementia with Lewy body brain.
    Irizarry, MC
    Growdon, W
    Gomez-Isla, T
    Newell, K
    Ingraham, A
    George, J
    Clayton, D
    Hyman, BT
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 509 - 509
  • [23] Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different?
    Tsuboi, Y
    Dickson, DW
    PARKINSONISM & RELATED DISORDERS, 2005, 11 : S47 - S51
  • [24] Treatment of Dementia with Lewy Bodies and Parkinson's Disease Dementia
    Ballard, Clive
    Kahn, Zunera
    Corbett, Anne
    DRUGS & AGING, 2011, 28 (10) : 769 - 777
  • [25] Depression in dementia with Lewy bodies and Parkinson's disease dementia
    Fritze, F.
    Ehrt, U.
    Aarsland, D.
    MOVEMENT DISORDERS, 2010, 25 (07) : S487 - S487
  • [26] Treatment of Dementia with Lewy Bodies and Parkinson’s Disease Dementia
    Clive Ballard
    Zunera Kahn
    Anne Corbett
    Drugs & Aging, 2011, 28 : 769 - 777
  • [28] β-Synuclein gene alterations in dementia with Lewy bodies
    Ohtake, H
    Limprasert, P
    Fan, Y
    Onodera, O
    Kakita, A
    Takahashi, H
    Bonner, LT
    Tsuang, DW
    Murray, IVJ
    Lee, VMY
    Trojanowski, JQ
    Ishikawa, A
    Idezuka, J
    Murata, M
    Toda, T
    Bird, TD
    Leverenz, JB
    Tsuji, S
    La Spada, AR
    NEUROLOGY, 2004, 63 (05) : 805 - 811
  • [29] Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies
    Attems, J.
    Jellinger, K.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 13 - 13
  • [30] Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
    Kurt A. Jellinger
    Amos D. Korczyn
    BMC Medicine, 16